aceTRV-2026-0313Version 1 · Certified
Reason for this version
Certified into the record
Canonical text (the exact bytes fingerprinted)
TRUVACE RECORD VERSION record: TRV-2026-0313 version: 1 kind: certified reason: Certified into the record timestamp: 2026-07-20T08:46:27.413179Z status: published lens: p_space sector: health headline: Embedded transparency in artificial intelligence: a prerequisite for equity and representation in AI-enabled clinical trials dek: Artificial intelligence is being embedded in clinical trial infrastructure, shaping who is identified, stratified, and analysed. Opaque models risk amplifying existing disparities in the evidence base. We argue that embedded transparency, the structural integration of ex ante interpretability, demographic auditability, documented uncertainty handling, and stakeholder-relative explanation, is a necessary, though not sufficient, condition for equitable AI-enabled trials, and propose governance recommendations acti… gain_title: (none) problem_title: Opaque AI models embedded in clinical trial infrastructure risk amplifying existing disparities in the evidence base by shaping who is identified and analyzed. trace_subject: (none) gain_reading: (none) gain_evidence: (none) problem_reading: Opaque AI models embedded in clinical trial infrastructure risk amplifying existing disparities in the evidence base by shaping who is identified and analyzed. problem_evidence: Opaque models risk amplifying existing disparities in the evidence base. | Artificial intelligence is being embedded in clinical trial infrastructure quick_read: As of the July 2026 publication date, the authors describe AI being embedded in clinical trial infrastructure and argue that opaque models risk amplifying disparities. They propose embedded transparency as a structural prerequisite for equitable trials and outline governance recommendations. This matters because trial infrastructure determines whose data informs evidence and treatment guidance. The paper does not report measured improvements in representation from an intervention, leaving uncertainty about effectiveness, implementation costs, and how transparency interacts with other drivers of inequity. limitation: tag: Model-prefilled problem key_points: AI is being embedded in clinical trial infrastructure and influences participant identification and stratification. | Authors define embedded transparency as structural integration of interpretability, demographic auditability, uncertainty handling, and stakeholder-relative explanation. | Paper proposes governance recommendations intended to be actionable across regulatory regimes. rundown: The authors conceptualize embedded transparency as ex ante interpretability, demographic auditability, documented uncertainty handling, and stakeholder-relative explanation built into trial systems. They frame opaque models as a risk factor for amplifying disparities in the evidence base and position transparency as a governance requirement across regulatory regimes. sources: - peer_reviewed | npj Digital Medicine | https://doi.org/10.1038/s41746-026-02987-7 | 2026-07-11 prev: 0000000000000000000000000000000000000000000000000000000000000000
- sha256
- 507d3e898d7993ee7659f094336910be9f9dda78938c80c47258ff57256bdc24
- previous
- 0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0313 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.